Does TRASTUZUMAB DERUXTECAN Cause Product use issue? 32 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Product use issue have been filed in association with TRASTUZUMAB DERUXTECAN (Enhertu). This represents 1.2% of all adverse event reports for TRASTUZUMAB DERUXTECAN.
32
Reports of Product use issue with TRASTUZUMAB DERUXTECAN
1.2%
of all TRASTUZUMAB DERUXTECAN reports
1
Deaths
12
Hospitalizations
How Dangerous Is Product use issue From TRASTUZUMAB DERUXTECAN?
Of the 32 reports, 1 (3.1%) resulted in death, 12 (37.5%) required hospitalization, and 4 (12.5%) were considered life-threatening.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRASTUZUMAB DERUXTECAN. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does TRASTUZUMAB DERUXTECAN Cause?
Death (384)
Off label use (258)
Nausea (251)
Myelosuppression (242)
Fatigue (186)
Malignant neoplasm progression (171)
Vomiting (140)
Diarrhoea (132)
Interstitial lung disease (130)
Pneumonitis (125)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which TRASTUZUMAB DERUXTECAN Alternatives Have Lower Product use issue Risk?
TRASTUZUMAB DERUXTECAN vs TRASTUZUMAB-DKST
TRASTUZUMAB DERUXTECAN vs TRASTUZUMAB-DTTB
TRASTUZUMAB DERUXTECAN vs TRASTUZUMAB EMTANSINE
TRASTUZUMAB DERUXTECAN vs TRASTUZUMAB-PKRB
TRASTUZUMAB DERUXTECAN vs TRASTUZUMAB-QYYP